In 2022, the gross profit of Chinese pharmaceutical firm Fosun Pharmaceutical was approximately ** billion yuan, increasing significantly from the previous year. Overall, the gross profits showed a fluctuating upward trend.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆÆ½â°æ can support your business.
Shanghai Fosun Pharmaceutical (Group). (March 27, 2023). Gross profit of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. from 2019 to 2022 (in billion yuan) [Graph]. In ÌÇÐÄÆÆ½â°æ. Retrieved July 23, 2026, from /statistics/1405622/fosun-pharmaceutical-gross-profit/
Shanghai Fosun Pharmaceutical (Group). "Gross profit of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. from 2019 to 2022 (in billion yuan)." Chart. March 27, 2023. ÌÇÐÄÆÆ½â°æ. Accessed July 23, 2026. /statistics/1405622/fosun-pharmaceutical-gross-profit/
Shanghai Fosun Pharmaceutical (Group). (2023). Gross profit of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. from 2019 to 2022 (in billion yuan). ÌÇÐÄÆÆ½â°æ. ÌÇÐÄÆÆ½â°æ Inc.. Accessed: July 23, 2026. /statistics/1405622/fosun-pharmaceutical-gross-profit/
Shanghai Fosun Pharmaceutical (Group). "Gross Profit of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. from 2019 to 2022 (in Billion Yuan)." ÌÇÐÄÆÆ½â°æ, ÌÇÐÄÆÆ½â°æ Inc., 27 Mar 2023, /statistics/1405622/fosun-pharmaceutical-gross-profit/
Shanghai Fosun Pharmaceutical (Group), Gross profit of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. from 2019 to 2022 (in billion yuan) ÌÇÐÄÆÆ½â°æ, /statistics/1405622/fosun-pharmaceutical-gross-profit/ (last visited July 23, 2026)
Gross profit of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. from 2019 to 2022 (in billion yuan) [Graph], Shanghai Fosun Pharmaceutical (Group), March 27, 2023. [Online]. Available: /statistics/1405622/fosun-pharmaceutical-gross-profit/